cjc-1295 ipamorelin clinical trial safety adverse events hormonal inquiry ipamorelin anti-aging benefits studies Sublingual CJC-1295 CJC-1295 + Ipamorelin – Growth

From your first appointment, we take time to understand your goals, your concerns, and what feels right for you before recommending any treatment

While direct clinical trials specifically on active acne vulgaris are limited, the observed benefits are highly relevant to acne-prone skin: Improved Skin Density and Thickness: Clinical studies have shown GHK-Cus ability to increase skin density and thickness, which can contribute to a plumper appearance and potentially reduce the visibility of shallow scars

Neuropharmacology 41 , 650663 (2001) Otwinowsky, Z

As CJC-1295 has yet to undergo human clinical trials, there is limited published research into dosing protocol

Trayhurn P, Beattie JH

45 Exclusion criteria included any contraindication to MRI, history of epilepsy, stroke, brain surgery, or structural brain disease, pregnancy, history of sulfur sensitivity, ongoing asthma or drug dependence, ongoing chronic diseases, history of mental illness, or acute infection during the prior 30 days